Get the Stockscreener App
4.82
2.55%
0.12
Liminatus Pharma Inc stock is traded at $4.82, with a volume of 89,908.
It is up +2.55% in the last 24 hours and down -30.45% over the past month.
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
See More
Previous Close:
$4.70
Open:
$4.71
24h Volume:
89,908
Relative Volume:
0.17
Market Cap:
$124.09M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-23.13%
1M Performance:
-30.45%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$4.70
$4.87
1-Week Range:
$4.20
$6.3075
52-Week Range:
$4.20
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Name
Liminatus Pharma Inc
Sector
Industry
Phone
213-273-5453
Address
6 CENTERPOINTE DR., LA PALMA
Compare LIMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
4.77 | 133.70M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.43 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.36 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.06 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
670.26 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
295.09 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Liminatus Pharma Inc Stock (LIMN) Latest News
Liminatus Pharma Rings the Closing Bell - Nasdaq
Is it the right time to buy Liminatus Pharma Inc. stockOutstanding risk-reward balance - Jammu Links News
What institutional investors are buying Liminatus Pharma Inc. stockFree Stock Selection - Jammu Links News
Liminatus Pharma Inc. Stock Analysis and ForecastMaximize returns with disciplined trading - Jammu Links News
Why Liminatus Pharma Inc. stock attracts strong analyst attentionReal Profit Trade Plan Suggestions Shared Widely - beatles.ru
What makes Liminatus Pharma Inc. stock price move sharplyHigh-yield trading alerts - Jammu Links News
Why is Liminatus Pharma Inc. stock attracting strong analyst attentionHigh-yield trading alerts - Jammu Links News
How many analysts rate Liminatus Pharma Inc. Equity Warrant as a “Buy”Invest confidently with data-backed picks - Jammu Links News
What are the technical indicators suggesting about Liminatus Pharma Inc.Free Trend-Following Techniques - Jammu Links News
How does Liminatus Pharma Inc. generate profit in a changing economyAccelerated financial growth - Jammu Links News
How volatile is Liminatus Pharma Inc. Equity Warrant stock compared to the marketAchieve consistent double-digit growth - Jammu Links News
What drives Liminatus Pharma Inc. Equity Warrant stock priceInvest confidently with professional advice - Jammu Links News
How does Liminatus Pharma Inc. Equity Warrant generate profit in a changing economyFree Investment Case Studies - Jammu Links News
What is the dividend policy of Liminatus Pharma Inc. Equity Warrant stockStay ahead with advanced stock screening tools - Jammu Links News
Is Liminatus Pharma Inc. Equity Warrant stock overvalued or undervaluedBreakthrough capital growth - Jammu Links News
What catalysts could drive Liminatus Pharma Inc. stock higher in 2025Superior risk-adjusted returns - Jammu Links News
What are Liminatus Pharma Inc. company’s key revenue driversCapitalize on momentum stocks early - Jammu Links News
What are the latest earnings results for Liminatus Pharma Inc. Equity WarrantFree Popular Stock Recommendations - Jammu Links News
What are Liminatus Pharma Inc. Equity Warrant company’s key revenue driversInvest confidently with actionable market data - Jammu Links News
How strong is Liminatus Pharma Inc. company’s balance sheetUnlock powerful insights from market experts - Jammu Links News
How does Liminatus Pharma Inc. compare to its industry peersAchieve breakthrough financial growth - Jammu Links News
What are analysts’ price targets for Liminatus Pharma Inc. Equity Warrant in the next 12 monthsDiscover hidden gems in the stock market - Jammu Links News
What analysts say about Liminatus Pharma Inc. Equity Warrant stockDiscover breakthrough stocks before the crowd - Jammu Links News
What makes Liminatus Pharma Inc. Equity Warrant stock price move sharplyInvest smarter with data-backed insights - Jammu Links News
What is the risk reward ratio of investing in Liminatus Pharma Inc. Equity Warrant stockWealth Building Review That Work - jammulinksnews.com
What is Liminatus Pharma Inc. company’s growth strategyExpert Picks Outlook For Beginners - jammulinksnews.com
What catalysts could drive Liminatus Pharma Inc. Equity Warrant stock higher in 2025Expert Picks Planner For Fast Growth - Jammu Links News
Is Liminatus Pharma Inc. forming a reversal patternAI Based High Gain Watchlist Scanner Shared - metal.it
When is Liminatus Pharma Inc. stock expected to show significant growthChart Pattern Planner For Beginners - Jammu Links News
Liminatus Pharma Inc. Company’s Quarterly Earnings Growth: What the Numbers SayQuick Gain Stock Watch With Indicators Reviewed - metal.it
😱🔥Liminatus Enters Crypto: $500 Million BNB Bomb Explodes!🤯💲 - Binance
Three Major Companies Announce $1.7 Billion in BNB Treasury Allocations, CZ Reacts - Coinspeaker
How does Liminatus Pharma Inc. Equity Warrant compare to its industry peersFree Stock Target Finder That Work - jammulinksnews.com
Custom Dashboard Highlights Liminatus Pharma Inc. Equity Warrant Price MomentumBuy Alerts With Low Risk Confirmation Noted - metal.it
Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative - Koreabizwire
What is the risk reward ratio of investing in Liminatus Pharma Inc. stockMaximize your portfolio’s growth potential - Jammu Links News
Liminatus Pharma Inc Stock (LIMN) Financials Data
There is no financial data for Liminatus Pharma Inc (LIMN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.36%
1.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):